CORCEPT THERAPEUTICS INC — Director's Dealing 2017

Mar 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2017-03-13

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-13	Common Stock	S	20568	$11.1292	Disposed	7534014	Indirect
2017-03-13	Common Stock	S	412	$11.1291	Disposed	151008	Indirect
2017-03-14	Common Stock	S	294105	$10.0089	Disposed	7239909	Indirect
2017-03-14	Common Stock	S	5895	$10.0089	Disposed	145113	Indirect
2017-03-15	Common Stock	S	273537	$10.2386	Disposed	6966372	Indirect
2017-03-15	Common Stock	S	5483	$10.2372	Disposed	139630	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	204210	Direct

Footnotes

F1: Reflects sales of common stock of the Issuer executed in multiple transactions at prices ranging from $11.10 to $11.305. The price reported reflects the weighted-average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F2: Reflects shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA"). Mr. Enright is a managing member of Longitude Capital Partners, LLC, the sole general partner of LVP and LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP and LCA, except to the extent of his pecuniary interest therein.

F3: Reflects sales of common stock of the Issuer executed in multiple transactions at prices ranging from $9.90 to $10.37. The price reported reflects the weighted-average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F4: Reflects sales of common stock of the Issuer executed in multiple transactions at prices ranging from $10.14 to $10.36. The price reported reflects the weighted-average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.